Ultraearly treatment on sudden deafness and the influence on superoxide dismutase and malonyldialdehyde of serum. | Canada Hyperbarics Skip to main content
Clinical Study Zhonghua er bi yan hou ke za zhi 2002

Ultraearly treatment on sudden deafness and the influence on superoxide dismutase and malonyldialdehyde of serum.

Wang W, Xu R, Yao M — Zhonghua er bi yan hou ke za zhi, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the effect of ultra-early treatment (within 6 hours) for sudden deafness, compared to later treatment, on hearing recovery and serum markers in 147 patients.

What They Found

Patients receiving ultra-early treatment (within 6 hours) for sudden deafness demonstrated significantly better hearing improvement compared to those treated within 15 days (P < 0.01) or after 15 days (P < 0.01). For instance, in the ultra-early group, 18 ears recovered and 9 significantly improved, whereas in the group treated within 15 days, 11 ears recovered and 16 significantly improved.

Canadian Relevance

This study was not conducted in Canada and has no direct Canadian connection.

Study Limitations

The study's findings may be limited by its non-randomised design and the age of the data.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 12772413
Year Published 2002
Journal Zhonghua er bi yan hou ke za zhi
MeSH Terms Adult; Combined Modality Therapy; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Malondialdehyde; Middle Aged; Nimodipine; Superoxide Dismutase

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology